We will provide women with the
breast cancer Diagnostics-as-a-Service
they are seeking
The Blue Box Biomedical Solutions
THE PROBLEM
THE SOLUTION
WE'RE BUILDING A PAIN-FREE, RADIATION-FREE AND ACCESSIBLE BREAST CANCER TEST FOR THEM.
SENSITIVITY
ACCURACY
SPECIFICITY
MAMMOGRAPHY
IN WOMEN AGED <50
73%
58%
88%
THE BLUE BOX
IN WOMEN AGED <50
85%
79%
71%
OUR MISSION
Women aged 20-45 cannot get screened for BC because existing solutions are unreliable. However, they want to. At The Blue Box, we have built a urine-based pain-free, low-cost, sensitive, radiation-free device to make breast cancer detection accessible.
In 2024, we’ll launch into the market, bringing The Blue Box to private gynaecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.
Incubated at...
Supported by...
Do you want to be the first to know when the blue box will hit the market?
​
Subscribe to our newsletter and never miss out on
The Blue Box journey!
